[96a5a0]: / output / allTrials / identified / NCT01983748_identified.json

Download this file

762 lines (762 with data), 33.4 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
{
"info": {
"nct_id": "NCT01983748",
"official_title": "A NON-COMMERCIAL, MULTICENTER, RANDOMIZED, TWO-ARMED, OPEN-LABEL PHASE III STUDY TO EVALUATE THE ADJUVANT VACCINATION WITH TUMOR RNA-LOADED AUTOLOGOUS DENDRITIC CELLS VERSUS OBSERVATION OF PATIENTS WITH RESECTED MONOSOMY 3 UVEAL MELANOMA",
"inclusion_criteria": "* Patients must suffer from melanoma of the uvea (stage T2, T3 and T4 [AJCC TNM grading 2009]).\n* Uveal melanoma must be resected and display a monosomy for chromosome 3 (will be determined by a validated qualitative analysis of loss of heterozygosity). Tumor material has to be stored appropriately in RNAlater solution for RNA preparation.\n* The patient has to be free of detectable tumor at the time point of study enrollment (adjuvant setting), as assessed by clinical inspection, abdominal sonography, chest X-ray and evaluation of the tumor-marker S-100..\n* Patients must have a WHO performance status of 0, 1 or 2 and must be in stable medical condition.\n* Patients must be between 18 and 75 years old and must be able and willing to give informed consent.\n* Women of child-bearing age must have a negative pregnancy test, and must oblige to use effective contraception until at least 4 weeks after the last vaccination.\n* Patients must be willing to get hospitalized for at least 4 hours following vaccination(s), and to cooperate for the whole period of the trial.\n* Patients must have fully recovered from surgery.\n* Signed informed consent\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 75 Years",
"exclusion_criteria": "* Any other major serious illness [e.g. active systemic infections, immunodeficiency disease, clinically significant heart disease, respiratory disease, bleeding disorders, cancer etc.] or a contraindication to leukapheresis.\n* Evidence for HIV-1, HIV -2, HTLV-1, HBV, or HCV infection.\n* Active autoimmune disease (such as but not limited to Lupus erythematosus, autoimmune thyroiditis or uveitis, multiple sclerosis, inflammatory bowel disease). Vitiligo and pathological laboratory results (autoantibodies) without clinical symptoms are, however, not an exclusion criterion.\n* Previous splenectomy or radiation therapy to the spleen.\n* Patients with organ allografts.\n* Concomitant treatment with chemotherapy, immunotherapy, any investigational drug and paramedical substances. Patients may receive concomitant medications to control symptoms such as analgetics, antihypertensive medication, etc.\n* History of other active malignant neoplasm within the preceding 5 years (excluding non-melanoma skin cancer or carcinoma in situ of the cervix).\n* Organic brain syndrome or significant psychiatric abnormality which would impede informed consent and / or AND preclude participation in the full protocol and follow up.\n* Positive pregnancy test / Pregnancy or lactation. If pregnancy occurs during the course of the trial to female patients in arm A or B, the patient has to be excluded.\n* Detection of metastases. If uveal melanoma metastases appear during the course of the trial, the patient has to be excluded.\n* Lack of compliance of the patient.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Patients must suffer from melanoma of the uvea (stage T2, T3 and T4 [AJCC TNM grading 2009]).",
"criterions": [
{
"exact_snippets": "melanoma of the uvea",
"criterion": "melanoma of the uvea",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "stage T2, T3 and T4 [AJCC TNM grading 2009]",
"criterion": "melanoma stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"T2",
"T3",
"T4"
]
}
]
}
]
},
{
"line": "* Uveal melanoma must be resected and display a monosomy for chromosome 3 (will be determined by a validated qualitative analysis of loss of heterozygosity). Tumor material has to be stored appropriately in RNAlater solution for RNA preparation.",
"criterions": [
{
"exact_snippets": "Uveal melanoma must be resected",
"criterion": "uveal melanoma",
"requirements": [
{
"requirement_type": "resection",
"expected_value": true
}
]
},
{
"exact_snippets": "display a monosomy for chromosome 3",
"criterion": "chromosome 3",
"requirements": [
{
"requirement_type": "monosomy",
"expected_value": true
}
]
},
{
"exact_snippets": "Tumor material has to be stored appropriately in RNAlater solution",
"criterion": "tumor material",
"requirements": [
{
"requirement_type": "storage",
"expected_value": "RNAlater solution"
}
]
}
]
},
{
"line": "* The patient has to be free of detectable tumor at the time point of study enrollment (adjuvant setting), as assessed by clinical inspection, abdominal sonography, chest X-ray and evaluation of the tumor-marker S-100..",
"criterions": [
{
"exact_snippets": "free of detectable tumor",
"criterion": "detectable tumor",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "clinical inspection",
"criterion": "clinical inspection",
"requirements": [
{
"requirement_type": "method",
"expected_value": "clinical inspection"
}
]
},
{
"exact_snippets": "abdominal sonography",
"criterion": "abdominal sonography",
"requirements": [
{
"requirement_type": "method",
"expected_value": "abdominal sonography"
}
]
},
{
"exact_snippets": "chest X-ray",
"criterion": "chest X-ray",
"requirements": [
{
"requirement_type": "method",
"expected_value": "chest X-ray"
}
]
},
{
"exact_snippets": "evaluation of the tumor-marker S-100",
"criterion": "tumor-marker S-100",
"requirements": [
{
"requirement_type": "evaluation",
"expected_value": "tumor-marker S-100"
}
]
}
]
},
{
"line": "* Patients must have a WHO performance status of 0, 1 or 2 and must be in stable medical condition.",
"criterions": [
{
"exact_snippets": "WHO performance status of 0, 1 or 2",
"criterion": "WHO performance status",
"requirements": [
{
"requirement_type": "value",
"expected_value": [
"0",
"1",
"2"
]
}
]
},
{
"exact_snippets": "stable medical condition",
"criterion": "medical condition",
"requirements": [
{
"requirement_type": "stability",
"expected_value": "stable"
}
]
}
]
},
{
"line": "* Patients must be between 18 and 75 years old and must be able and willing to give informed consent.",
"criterions": [
{
"exact_snippets": "Patients must be between 18 and 75 years old",
"criterion": "age",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 18,
"unit": "years"
},
{
"operator": "<=",
"value": 75,
"unit": "years"
}
]
}
}
]
},
{
"exact_snippets": "must be able and willing to give informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
},
{
"requirement_type": "willingness",
"expected_value": true
}
]
}
]
},
{
"line": "* Women of child-bearing age must have a negative pregnancy test, and must oblige to use effective contraception until at least 4 weeks after the last vaccination.",
"criterions": [
{
"exact_snippets": "Women of child-bearing age",
"criterion": "gender and reproductive status",
"requirements": [
{
"requirement_type": "gender",
"expected_value": "female"
},
{
"requirement_type": "reproductive status",
"expected_value": "child-bearing age"
}
]
},
{
"exact_snippets": "must have a negative pregnancy test",
"criterion": "pregnancy test result",
"requirements": [
{
"requirement_type": "result",
"expected_value": "negative"
}
]
},
{
"exact_snippets": "must oblige to use effective contraception",
"criterion": "contraception usage",
"requirements": [
{
"requirement_type": "usage",
"expected_value": true
}
]
},
{
"exact_snippets": "until at least 4 weeks after the last vaccination",
"criterion": "contraception duration",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* Patients must be willing to get hospitalized for at least 4 hours following vaccination(s), and to cooperate for the whole period of the trial.",
"criterions": [
{
"exact_snippets": "Patients must be willing to get hospitalized for at least 4 hours following vaccination(s)",
"criterion": "hospitalization",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "hours"
}
}
]
},
{
"exact_snippets": "Patients must be willing ... to cooperate for the whole period of the trial",
"criterion": "cooperation",
"requirements": [
{
"requirement_type": "duration",
"expected_value": "whole period of the trial"
}
]
}
]
},
{
"line": "* Patients must have fully recovered from surgery.",
"criterions": [
{
"exact_snippets": "fully recovered from surgery",
"criterion": "recovery from surgery",
"requirements": [
{
"requirement_type": "status",
"expected_value": "fully recovered"
}
]
}
]
},
{
"line": "* Signed informed consent",
"criterions": [
{
"exact_snippets": "Signed informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "signed",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 75 Years",
"criterions": [
{
"exact_snippets": "maximum age of 75 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 75,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Any other major serious illness [e.g. active systemic infections, immunodeficiency disease, clinically significant heart disease, respiratory disease, bleeding disorders, cancer etc.] or a contraindication to leukapheresis.",
"criterions": [
{
"exact_snippets": "active systemic infections",
"criterion": "systemic infections",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "immunodeficiency disease",
"criterion": "immunodeficiency disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "clinically significant heart disease",
"criterion": "heart disease",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "clinically significant"
}
]
},
{
"exact_snippets": "respiratory disease",
"criterion": "respiratory disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "bleeding disorders",
"criterion": "bleeding disorders",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "cancer",
"criterion": "cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "contraindication to leukapheresis",
"criterion": "contraindication to leukapheresis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Evidence for HIV-1, HIV -2, HTLV-1, HBV, or HCV infection.",
"criterions": [
{
"exact_snippets": "Evidence for HIV-1",
"criterion": "HIV-1 infection",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "HIV -2",
"criterion": "HIV-2 infection",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "HTLV-1",
"criterion": "HTLV-1 infection",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "HBV",
"criterion": "HBV infection",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "HCV infection",
"criterion": "HCV infection",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Active autoimmune disease (such as but not limited to Lupus erythematosus, autoimmune thyroiditis or uveitis, multiple sclerosis, inflammatory bowel disease). Vitiligo and pathological laboratory results (autoantibodies) without clinical symptoms are, however, not an exclusion criterion.",
"criterions": [
{
"exact_snippets": "Active autoimmune disease (such as but not limited to Lupus erythematosus, autoimmune thyroiditis or uveitis, multiple sclerosis, inflammatory bowel disease)",
"criterion": "active autoimmune disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Vitiligo and pathological laboratory results (autoantibodies) without clinical symptoms are, however, not an exclusion criterion",
"criterion": "vitiligo",
"requirements": [
{
"requirement_type": "exclusion",
"expected_value": false
}
]
},
{
"exact_snippets": "pathological laboratory results (autoantibodies) without clinical symptoms are, however, not an exclusion criterion",
"criterion": "pathological laboratory results (autoantibodies) without clinical symptoms",
"requirements": [
{
"requirement_type": "exclusion",
"expected_value": false
}
]
}
]
},
{
"line": "* Previous splenectomy or radiation therapy to the spleen.",
"criterions": [
{
"exact_snippets": "Previous splenectomy",
"criterion": "splenectomy",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "radiation therapy to the spleen",
"criterion": "radiation therapy to the spleen",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients with organ allografts.",
"criterions": [
{
"exact_snippets": "Patients with organ allografts",
"criterion": "organ allograft",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Concomitant treatment with chemotherapy, immunotherapy, any investigational drug and paramedical substances. Patients may receive concomitant medications to control symptoms such as analgetics, antihypertensive medication, etc.",
"criterions": [
{
"exact_snippets": "Concomitant treatment with chemotherapy",
"criterion": "concomitant chemotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Concomitant treatment with ... immunotherapy",
"criterion": "concomitant immunotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Concomitant treatment with ... any investigational drug",
"criterion": "concomitant investigational drug",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Concomitant treatment with ... paramedical substances",
"criterion": "concomitant paramedical substances",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* History of other active malignant neoplasm within the preceding 5 years (excluding non-melanoma skin cancer or carcinoma in situ of the cervix).",
"criterions": [
{
"exact_snippets": "History of other active malignant neoplasm within the preceding 5 years",
"criterion": "active malignant neoplasm",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
},
{
"requirement_type": "time frame",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 5,
"unit": "years"
}
]
}
}
]
},
{
"exact_snippets": "excluding non-melanoma skin cancer or carcinoma in situ of the cervix",
"criterion": "type of cancer",
"requirements": [
{
"requirement_type": "exclusion",
"expected_value": [
"non-melanoma skin cancer",
"carcinoma in situ of the cervix"
]
}
]
}
]
},
{
"line": "* Organic brain syndrome or significant psychiatric abnormality which would impede informed consent and / or AND preclude participation in the full protocol and follow up.",
"criterions": [
{
"exact_snippets": "Organic brain syndrome",
"criterion": "organic brain syndrome",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "significant psychiatric abnormality",
"criterion": "psychiatric abnormality",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "significant"
}
]
}
]
},
{
"line": "* Positive pregnancy test / Pregnancy or lactation. If pregnancy occurs during the course of the trial to female patients in arm A or B, the patient has to be excluded.",
"criterions": [
{
"exact_snippets": "Positive pregnancy test",
"criterion": "pregnancy test",
"requirements": [
{
"requirement_type": "result",
"expected_value": "positive"
}
]
},
{
"exact_snippets": "Pregnancy or lactation",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Pregnancy or lactation",
"criterion": "lactation",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Detection of metastases. If uveal melanoma metastases appear during the course of the trial, the patient has to be excluded.",
"criterions": [
{
"exact_snippets": "Detection of metastases",
"criterion": "metastases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "uveal melanoma metastases appear during the course of the trial",
"criterion": "uveal melanoma metastases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Lack of compliance of the patient.",
"criterions": [
{
"exact_snippets": "Lack of compliance of the patient",
"criterion": "patient compliance",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}